Open AccessRemote Monitoring in Clinical Trials During the COVID‐19 Pandemic
Author(s) -
Izmailova Elena S.,
Ellis Robert,
Benko Christopher
Publication year - 2020
Publication title -
clinical and translational science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 44
eISSN - 1752-8062
pISSN - 1752-8054
DOI - 10.1111/cts.12834
Subject(s) - pandemic , covid-19 , usable , clinical trial , data collection , medicine , remote sensing , computer science , data science , disease , geography , outbreak , virology , pathology , infectious disease (medical specialty) , world wide web , statistics , mathematics
The coronavirus disease 2019 (COVID‐19) pandemic has rapidly challenged the pharmaceutical industry to implement remote clinical trials. The industry’s lack of extensive experience with remote measurements initiates multiple questions about how to select candidates for remote collection, their validity, and regulatory implications of moving certain assessments to a remote mode. We propose a decision tree for migration of clinic to remote assessments and highlight activities required to ensure that these measurements are valid, safe, and usable.